Literature DB >> 7681466

Effect of human insulin-like growth factor-binding protein-1 on the half-life and action of administered insulin-like growth factor-I in rats.

M S Lewitt1, H Saunders, G J Cooney, R C Baxter.   

Abstract

We have determined the effect of human insulin-like growth factor-binding protein-1 (hIGFBP-1) on the circulating half-life (t1/2) of human insulin-like growth factor-I (hIGF-I) and on hIGF-I-stimulated 2-deoxyglucose uptake in tissues of the cannulated conscious rat. The levels of hIGF-I in rat serum were measured by radioimmunoassay. The assay was carried out in the presence of partially purified rat IGF to remove interference from any IGFBPs not removed by acid-ethanol extraction. An intravenous bolus of 12.5 micrograms hIGF-I, given to 12-h fasted rats, disappeared from the circulation in a double exponential fashion with an initial t1/2 of 1.2 +/- 0.2 min (n = 8), which increased to 5.3 +/- 0.9 min when 100 micrograms hIGFBP-1 was co-administered (n = 5; P < 0.001). The second phase of disappearance of hIGF-I indicated an apparent t1/2 of 35.7 +/- 5.6 min which was not significantly altered by the co-infusion of hIGFBP-1. Circulating hIGFBP-1, measured with a primate-specific radioimmunoassay, disappeared in a single exponential fashion with a t1/2 of 8.8 +/- 0.7 min. A tracer amount of 2-deoxy-[1-3H]glucose was administered intravenously at the same time as the peptide(s) and the rate of tissue uptake and phosphorylation of 2-deoxy-[1-3H]glucose determined. Compared with a control group (n = 4), hIGF-I significantly stimulated hexose uptake into heart, soleus and red quadriceps muscles and hIGFBP-1 partially reversed this effect.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681466     DOI: 10.1677/joe.0.1360253

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  4 in total

Review 1.  Cellular actions of insulin-like growth factor binding proteins.

Authors:  R J Ferry; L E Katz; A Grimberg; P Cohen; S A Weinzimer
Journal:  Horm Metab Res       Date:  1999 Feb-Mar       Impact factor: 2.936

Review 2.  Genetics, chemistry, and function of the IGF/IGFBP system.

Authors:  P F Collett-Solberg; P Cohen
Journal:  Endocrine       Date:  2000-04       Impact factor: 3.633

3.  Design and fabrication of a biodegradable, covalently crosslinked shape-memory alginate scaffold for cell and growth factor delivery.

Authors:  Lin Wang; Janet Shansky; Cristina Borselli; David Mooney; Herman Vandenburgh
Journal:  Tissue Eng Part A       Date:  2012-08-23       Impact factor: 3.845

4.  Amino acid infusion during anesthesia attenuates the surgery induced decline in IGF-1 and diminishes the "diabetes of injury".

Authors:  Mats K E B Wallin; Eva Selldén; Staffan Eksborg; Kerstin Brismar
Journal:  Nutr Metab (Lond)       Date:  2007-01-09       Impact factor: 4.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.